Services
Navigating Complex Drug Development.
Optimizing Portfolio Value.
our core capabilities and services
Executive Project Management & Program Leadership
Our Executive Project Management & Program Leadership ensures that your biotechnology projects are strategically guided, expertly led, and delivered on time through seamless coordination of cross-functional teams and regulatory strategies.
Cross-Functional Oversight
Directing non-clinical, CMC, clinical, safety, and regulatory strategies to ensure seamless milestone execution.
Governance & Process Infrastructure
Designing and deploying comprehensive project management structures, decision-making governance, and optimal GO/NO GO criteria.
Operational Turnarounds
(Re)building high-performing project management and clinical operations functions to maximize efficiency and accelerate aggressive timelines.
Strategic Planning & Asset Valuation
With proven expertise in Global Regulatory Filings, we manage critical milestones, including IND/NDA submissions and health authority meetings, to ensure compliance and pave the way for successful clinical trials and market entry.
Decision Analysis
Facilitating interdisciplinary dialogue to generate creative, actionable development alternatives and risk-mitigation plans.
Portfolio Valuation
Modeling technical and commercial uncertainty (NPV forecasting) to support VC-funding, licensing, and due diligence efforts.
Process Optimization
Evaluating existing R&D processes to eliminate redundancies, establish Centers of Excellence, and implement metrics that drive business wins.
Regulatory & Clinical Execution
We specialize in Governance & Process Infrastructure, designing robust project management frameworks and optimal decision-making criteria to promote efficient milestone execution and effective resource allocation throughout drug development.
Global Regulatory Filings
Proven hands-on management of critical milestones, including IND/NDA submissions, health authority meetings, and FDA Advisory Committee preparations.
End-to-End Clinical Operations
Experience steering global programs spanning Phase I first-in-human through Phase III pivotal trials and successful commercial launch.
Trusted Excellence
What Sets Switchback BioStrategy Group Apart
A Rare Combination of Scientific Rigor, Executive Leadership, and Cross-Functional Expertise
Unparalleled Cross-Functional Leadership with Deep Scientific Roots
Unlike traditional consultants, Switchback Biostrategy Group brings nearly four decades of hands-on executive experience across neuroscience, statistics, and senior leadership roles at Amgen, Bristol-Myers Squibb, Johnson & Johnson, and leading biotech companies. This rare blend allows us to provide truly integrated strategic guidance that bridges science, clinical operations, regulatory affairs, and commercial strategy.
Rigorous Data-Driven Decision Making & Risk Mitigation
We combine advanced statistical precision with practical portfolio valuation modeling (including NPV forecasting under technical and commercial uncertainty). This enables clearer GO/NO-GO decisions, creative development alternatives, and higher-confidence outcomes for funding, licensing, and regulatory milestones.
Proven Ability to Build and Transform High-Performing Development Organizations
We don’t just advise — we design and implement robust project management infrastructures, governance frameworks, and operational turnarounds. Our track record spans successful IND/NDA submissions, global Phase I–III programs, and commercial launches across more than a dozen therapeutic areas.
Let’s Strategize Your Next Milestone.
Partner with Switchback BioStrategy Group to bring clarity, efficiency and clinical precision to your drug development portfolio
